ribocytokine IL-7 BNT152
Term · Oncology and biomedicine · MLC-T-ONC-016535
A formulation consisting of lipid nanoparticles (LNPs) encapsulating nucleoside-modified messenger RNA (mRNA) encoding the endogenous cytokine interleukin-7 (IL-7), with potential immunostimulating activity. Upon administration, ribocytokine IL-7 BNT152 is taken up by cells and the expressed IL-7 targets and binds to the IL-7 receptor (IL7R). The binding of IL-7 to IL7R activates IL7/IL7R-mediated signaling, which activates B and T lymphocytes, may improve immune recovery and activation, and may enhance anti-tumor immune responses.
| Identifier | MLC-T-ONC-016535 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | human interleukin-7 mRNA-encoded BNT152 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016535",
"term": "ribocytokine IL-7 BNT152",
"field": "Oncology and biomedicine",
"definition": "A formulation consisting of lipid nanoparticles (LNPs) encapsulating nucleoside-modified messenger RNA (mRNA) encoding the endogenous cytokine interleukin-7 (IL-7), with potential immunostimulating activity. Upon administration, ribocytokine IL-7 BNT152 is taken up by cells and the expressed IL-7 targets and binds to the IL-7 receptor (IL7R). The binding of IL-7 to IL7R activates IL7/IL7R-mediated signaling, which activates B and T lymphocytes, may improve immune recovery and activation, and may enhance anti-tumor immune responses.",
"synonyms": [
"human interleukin-7 mRNA-encoded BNT152"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ribocytokine-il-7-bnt152/"
}
Record 14,466 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.